Showing results (51-60 of 316) with videos related to

Sort By:
Pageof 32
Neuropsychiatric Disease and Treatment|March 31, 2022
Early Lipid Metabolic Effects of the Anti-Psychotic Drug Olanzapine on Weight Gain and the Associated Gene ExpressionChien-Chih Chen, Toshiaki Nakano, Li-Wen Hsu, et al.
Clinical and Experimental Nephrology|April 30, 2025
Epidemiological study of renal involvement in sarcoidosis in Japan using the Japan Renal Biopsy RegistryYoshinori Kamata, Tsuneo Konta, Toshiaki Nakano, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 8, 2023
Determinants of the effectiveness of bezafibrate combined with ursodeoxycholic acid in patients with primary biliary cholangitisKosuke Matsumoto, Junko Hirohara, Akihito Takeuchi, et al.
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|May 13, 2026
Hyperphosphatemia-Related Mortality Is Modified by Serum Albumin and Creatinine Levels in Hemodialysis Patients: The Q-Cohort StudyShunsuke Yamada, Hokuto Arase, Masanori Tokumoto, et al.
Kidney Medicine|July 31, 2026
Association of Serum Chloride Concentration With All-Cause and Cardiovascular Mortality in Patients Undergoing Peritoneal Dialysis: The Fukuoka Peritoneal Dialysis RegistryTomoya Hamashoji, Shoji Tsuneyoshi, Kazuhiro Okamura, et al.
Scientific Reports|September 28, 2023
Magnesium inhibits peritoneal calcification as a late-stage characteristic of encapsulating peritoneal sclerosisSeishi Aihara, Shunsuke Yamada, Shumei Matsueda, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|November 9, 2019
Higher Cholesterol Level Predicts Cardiovascular Event and Inversely Associates With Mortality in Hemodialysis Patients: 10-Year Outcomes of the Q-Cohort StudyToshiaki Nakano, Hiroto Hiyamuta, Ryusuke Yotsueda, et al.
Clinical and Experimental Nephrology|August 4, 2022
Current antihypertensive treatment and treatment-resistant hypertension in Japanese patients with chronic kidney diseaseAkihiro Tsuchimoto, Shigeru Tanaka, Hiromasa Kitamura, et al.
Renal Failure|March 27, 2019
Hypercalcemia and acute kidney injury induced by eldecalcitol in patients with osteoporosis: a case series of 32 patients at a single facilitySeishi Aihara, Shunsuke Yamada, Hideaki Oka, et al.
Kidney International|August 3, 2020
Arginase 2 is a mediator of ischemia-reperfusion injury in the kidney through regulation of nitrosative stressMasatoshi Hara, Kumiko Torisu, Keigo Tomita, et al.
Pageof 32